Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q1 2023 · 10-Q
Revenue—
Net Income-$2.15M-$2.15MN/M vs Q1 2022 EPS Diluted-$0.03-$0.03N/M vs Q1 2022 Operating Income-$2,077,804N/M Operating Cash Flow-$284,707N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
Free Cash Flowderived-$292,745N/M ended Oct 31, 2022 · filed Dec 14, 2022 · 44 d after period end